Delivery Order SPE2DB22D3501-SPE2DB25FXB57
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Hydromorphone 1 mg/mL vials with a firm fixed price ceiling value of $2,013.12 and an ultimate completion date of August 11, 2025. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,127.10 to AmerisourceBergen Drug Corp for Hydromorphone 1 mg/ml, a controlled pharmaceutical used in pain management and palliative care. Issued on July 21, 2025, with an ultimate completion date of July 22, 2025, this firm fixed-price delivery order was competitively awarded without set-aside designation. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Hydromorphone HCL ER Tablets 16mg, with a contract ceiling value of $6,259.66 and a completion date of August 5, 2025. This competitive award, made without set-aside designation, is classified as a firm fixed price delivery order and represents a continuation of the federal government's ongoing pharmaceutical procurement through established...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $2,823.18 firm fixed-price delivery order is for the supply of Hydromorphone 1 mg/ml, a pain management medication. The contract has an ultimate completion date of April 30, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to...
- The Defense Logistics Agency awarded a delivery order valued at $1,348.21 to AmerisourceBergen Drug Corp for Hydromorphone HCL ER 8 mg tablets (100-count supply) with a completion date of July 28, 2025. This contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.44 firm fixed-price delivery order is for the supply of 1 mg/mL hydromorphone vials, a pain management medication. The contract has an ultimate completion date of November 15, 2023 and is not subject to any set-aside requirements, indicating open competition. AmerisourceBergen holds a $999,999,999...
- This contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,303.20 firm fixed-price delivery order is for HYDROMORPHONE 500 MG/50 ML VL 50ML, a pharmaceutical product. The contract has a completion date of February 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Hydromorphone 1ML 10S, a pharmaceutical product. The $1,271.61 delivery order was issued under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the...
- The Defense Logistics Agency awarded a $96,120 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 10 mg/ml vials of hydromorphone. The single day contract has a period of performance from September 27 through September 28, 2023, with all work to be conducted by Amerisourcebergen at its facility in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order falls under a larger blanket purchase...
- This federal contract award is for the delivery of hydromorphone 1 mg/ml vials, a pain management medication, to the Defense Logistics Agency (DLA). The $1,468.76 firm fixed-price delivery order was issued on August 8, 2022 to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of August 9, 2022 and does not include any set-aside requirements. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXB57Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,144.88 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Hydromorphone 2 mg/ml, a narcotic pain management pharmaceutical. This firm fixed-price delivery order, which is expected to be completed by August 29, 2025, carries no set-aside designation and represents a competitively awarded transaction under open competition. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support for the Defense Health Agency and U.S. Coast Guard. The company, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of federal contract awards demonstrating its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/28/25 |